MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. CPRX
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Catalyst Pharmaceuticals (CPRX) Revenue & Earnings 2020-2026

Revenue, EBITDA, operating income, net income, EPS, and shares

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares across quarters

TTM Revenue
$596.96M
11.7%
Q. Revenue
$149.39M
TTM EBITDA
$267.64M
15.7%
TTM Op. Income
$267.64M
15.7%
Q. Op. Income
$73.23M
TTM Net Income
$221.32M
12.1%
Q. Net Income
$63.73M
EPS
$0.52
Shares Out.
$122.25M
0.6%
$596.96M in TTM revenue grew 11.7% YoY, reaching $149.39M last quarter. TTM EBITDA of $267.64M and TTM operating income of $267.64M show growth is flowing through to the bottom line. TTM net income of $221.32M means revenue is converting into profit.
TTM Revenue
Reveals whether the core business is growing or shrinking
Quarterly Revenue
Highlights seasonal patterns and short-term momentum
TTM EBITDA
Shows if underlying operating profitability is improving
Quarterly EBITDA
Tracks near-term operating profitability trends
TTM Operating Income
Smoothed operating profit over the past four quarters
Quarterly Operating Income
Profit from core operations before financing costs
TTM Net Income
The bottom line — is the company making more money?
Quarterly Net Income
Short-term profit after all expenses and taxes
EPS
Earnings per share — profit attributable to each share
Shares Outstanding
Declining means buybacks benefit remaining holders